Physician profile
Michael Timothy Stowell
NPI 1639165525
$743.56
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $155 · 2021: $54.43.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $219.62 | 2019-2020 | |
| Pacira Therapeutics, INC. | $121.92 | 2019-2021 | |
| Csl Behring | $95.98 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $90.42 | 2019-2020 | |
| Ermi LLC | $45.31 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $43.15 | 2019 | |
| Heron Therapeutics, INC. | $22.69 | 2021 | |
| Bioventus LLC | $22.25 | 2019 | |
| Fidia Pharma USA INC. | $21.42 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $18.68 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.23 | 2019 | |
| Smith+Nephew, INC. | $13.43 | 2019 | |
| Djo, LLC | $11.46 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.